Sign In

Randall Moreadith, MD, PhD

Chief Development Officer

Dr. Randall Moreadith, MD, PhD, is a highly experienced CEO with a remarkable track record in drug development spanning over 25 years. He possesses a diverse skill set in developing a wide range of therapeutics, including biologics, small molecules, polymer therapeutics, antibody drug conjugates, gene therapy, and devices. Dr. Moreadith is a physician-scientist with a solid educational background, holding an MD with a focus on Internal Medicine - Cardiology from Duke University School of Medicine, a PhD in Molecular Genetics from Johns Hopkins University, and completing a fellowship in Genetics at Harvard University. He also has Executive Management training from SMU.

During his career, Dr. Moreadith has held key leadership positions in various prominent organizations. He served as the Chief Development Officer, President, and CEO at Serina Therapeutics, Inc., contributed as the Former Chief Development Officer at Nektar Therapeutics, acted as the Executive VP and Chief Medical Officer at Cardium Therapeutics, held the role of Chief Medical Officer at Renovis, Inc., and was appointed as the President and Chief Operating Officer at ThromboGenics, Ltd.

Randall Moreadith, MD, PhD
Add to my network

Location

Huntsville, Alabama, United States